STOCK TITAN

Perceptive discloses 4.3% Artivion stake—2,020,000 shares owned

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd. filed an amended Schedule 13G reporting beneficial ownership of 2,020,000 shares of Artivion, Inc. (AORT) common stock, representing 4.3% of the class. The percentage is based on 47,374,939 shares outstanding as of October 31, 2025, as disclosed by the company.

The filers report shared voting power and shared dispositive power over 2,020,000 shares, with no sole voting or dispositive power. They certify the holdings were not acquired to change or influence control of Artivion.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/14/2025
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:11/14/2025
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:11/14/2025

FAQ

What did Perceptive disclose about AORT in this Schedule 13G/A?

They reported beneficial ownership of 2,020,000 shares of Artivion common stock, or 4.3% of the class.

What share count did the 4.3% stake in AORT rely on?

The percentage is based on 47,374,939 shares outstanding as of October 31, 2025 from Artivion’s Form 10-Q.

Who are the reporting persons in the AORT 13G/A filing?

The reporting persons are Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd.

What voting and dispositive powers were reported for AORT shares?

They report shared voting power: 2,020,000 and shared dispositive power: 2,020,000, with 0 sole power for each.

Does the filing state an intent to influence control of Artivion (AORT)?

No. The filers certify the securities were not acquired and are not held to change or influence control.

What is the type/classification of the reporting persons?

They are classified as IA (investment adviser), IN (individual), and CO (corporation).

What is the date of the event requiring this AORT filing?

The event date listed is September 30, 2025.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.75B
43.32M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW